On April 14, 2026, Immunic, Inc. held a Special Meeting where shareholders approved a 1-for-10 reverse stock split of the company's shares, effective April 27, 2026. 70,622,667 out of 130,464,825 shares were represented at the meeting, with 57,404,749 votes in favor.